Asset
PEGIPANERMIN
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04370236 | phase2_3 | terminated | 2020-10-21 | 2021-10-13 | Inmune Bio, Inc. | INB03 for the Treatment of Pulmonary Complications From COVID-19 |
FDA applications (0)
This company has no applications containing this asset.